Patrick Dawson, OD
Optometrist · Springfield, OHNPI 1437153814
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 85.6% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $7,657, 5.4 times the $1,405 reported in 2019. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $224.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$14K
- Johnson & Johnson Vision Care, Inc.$2K
- Alcon$293
- Bausch & Lomb Americas Inc.$113
- Johnson & Johnson$110
- Biotissue Holdings Inc.$68
- plus $72 from 4 others
Across 3 payments — averaging $3246.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson Vision Care, Inc.$10K
What the payments were for
- Consulting fees$2,28014%
- Speaking & faculty fees$6,29037%
- Travel & lodging$5,83235%
- Food & beverage$2,42114%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 27 | $14,393 |
| Johnson & Johnson Vision Care, Inc. | 29 | $1,774 |
| Alcon | 5 | $293 |
| Bausch & Lomb Americas Inc. | 6 | $113 |
| Johnson & Johnson | 1 | $110 |
| Biotissue Holdings Inc. | 2 | $68 |
| ABB Con-cise Optical Group LLC | 2 | $24 |
| Astellas Pharma US Inc | 1 | $20 |
| Oyster Point Pharma, Inc. | 1 | $14 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MyDay Contact Lens$7,875
- Clariti Contact Lens$4,547
- Acuvue$1,114
- TOTAL30$132
- DAILIES TOTAL1$117
- XARELTO$110
How this compares
$16,822 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 111 | $1,126 |
| Timolol Maleate | 25 | $164 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Springfield
- Mile BrujicBowling Green$1.3M
- Gregory DenaeyerColumbus$846K
- Cory LappinMontgomery$367K
- Chris SmileyColumbus$305K
- Thomas ChesterCleveland$300K
- Carly RoseCincinnati$203K
- Wendy HallierReynoldsburg$200K
- John LahrCincinnati$145K
- Erin RueffColumbus$131K
- Mary YackeyCincinnati$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.